Managing Severe Pneumonia in the ICU: Addressing Drug-Resistant HABP and VABP

Availability

On-Demand

Expires on Oct 11, 2027

Credit Offered

No Credit Offered

Follow an evolving ICU patient case and make real-world decisions in the management of severe hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP). This concise, mobile-friendly learning experience combines interactive clinical decision points with expert faculty insights to help you recognize early clinical clues and resistance risks, select appropriate treatment strategies, and use diagnostic and local resistance data to optimize therapy. Explore additional resources along the way to take your learning further.

Recognize early signs of HABP/VABP in patients who are critically ill.
Identify risk factors for multidrug-resistant pathogens, including nonfermenters and carbapenem-resistant Acinetobacter baumannii.
Apply evidence-based treatment strategies for HABP/VABP caused by nonfermenters.
Use local data and diagnostics to optimize therapy and improve outcomes.

This non-CME credit education is brought to you by CHEST and sponsored by Innoviva Specialty Therapeutics, Inc.